Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting

Journal of Vascular Surgery

Volumn 32, Issue 3, 2000, Pages 506-518

  Timaran, Carlos H ^a   Stevens, Scott L ^a   Grandas, Oscar H ^a   Piercy, Kenneth T ^a   Freeman, Michael B ^a   Goldman, Mitchell H ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; CLAUDICATION; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; FEMOROPOPLITEAL BYPASS; GRAFT FAILURE; GRAFT PATENCY; HUMAN; LIMB SALVAGE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POLITEF IMPLANT; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; THROMBOEMBOLISM;

EID: 0033823297     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2000.108641     Document Type: Article

References (39)

1. Surgical treatment of infrainguinal arterial occlusive disease in women
2. Outcome of infrainguinal arterial reconstruction in women
3. The impact of gender on the results of arterial bypass with in situ greater saphenous vein
4. The influence of gender on the outcome of arterial procedures in the lower extremity
5. Sex differences in coronary-heart disease. Why are women so superior? The 1995 Ancel Keys Lecture
6. Hormone therapy to prevent disease and prolong life in postmenopausal women
7. The protective effects of estrogen on the cardiovascular system
8. Postmenopausal hormone therapy and mortality
9. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
10. Recommended standards for reports dealing with lower extremity ischemia: Revised version
11. Prediction of the immediate outcome of femoropopliteal saphenous vein bypass by angiographic runoff score
12. Angiographic runoff score as a predictor of outcome following femorocrural bypass surgery
13. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions
14. What is the proper role of polytetrafluoroethylene grafts in infrainguinal reconstruction?
15. Present status of reversed vein bypass grafting: Five-year results of a modern series
16. Basic data related to infrainguinal revascularization procedures
17. Chronic lower-extremity ischemia, part II
18. Long-term results of infrainguinal revascularization with polytetrafluoroethyene: A ten-year experience
19. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review
20. Non-parametric estimation from incomplete observations
21. Regression models and life tables
22. Multivariate survival analysis using Cox's regression model
23. Femoropopliteal vein grafts for intermittent claudication
24. Femoropopliteal bypass for limb salvage
25. Durability of the tibial artery bypass in diabetic patients
26. Menopause and hormone replacement therapy
27. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators
28. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: A 1-year, double-blind, placebo-controlled study
29. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
30. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
31. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP
32. Risk of venous thromboembolism in users of hormone replacement therapy
33. Prospective study of exogenous hormones and risk of pulmonary embolism in women
34. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens
35. Diabetes and cardiovascular disease: The Framingham study
36. The effect of a surveillance programme on the patency of synthetic infrainguinal bypass grafts
37. Diabetes, intermittent claudication, and risk of cardiovascular events: The Framingham Study
38. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Poncho Bernardo Study